Tango Therapeutics, Inc. (TNGX)
Nasdaq: TNGX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2020
Who owns Tango Therapeutics, Inc.
As filed with the SECHolders of 5% or more
9
Davis Aaron I. holds 10% of Common Stock, $0.001 par value per share, as its SCHEDULE 13D/A filed Jan 2, 2025 says.
Directors and officers
11
report now, of 34 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 9 named at left.
Holders of 5% or moreshare of the class, as filed
Davis Aaron I.
SCHEDULE 13D/A · filed Jan 2, 2025 · Common Stock, $0.001 par value per share
Dapice Joshua J.
SCHEDULE 13G/A · filed Feb 6, 2026 · Common stock, par value $0.001 per share (the "Shares")
Farallon Capital Management, L.L.C.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, par value $0.001 per share (the "Shares")
RTW Investments, LP
SCHEDULE 13G · filed May 15, 2026 · Common Stock, par value $0.001 per share
Dapice Joshua J.
SCHEDULE 13G/A · filed May 11, 2026 · Common stock, par value $0.001 per share (the "Shares") · 9.7% in Nov 12, 2025
TCG Crossover GP II, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 8.1% in May 15, 2026
Fmr LLC
SCHEDULE 13G · filed May 6, 2026 · COMMON STOCK · 0% in Dec 6, 2024
Blackrock, Inc.
SCHEDULE 13G · filed Jan 21, 2026 · Common Stock · 5% in Jul 17, 2025
Goldman Sachs Group Inc.
SCHEDULE 13G · filed Aug 14, 2026 · Common stock, par value $0.001 per share
Third Rock Ventures IV, L.P.
SCHEDULE 13D/A · filed Feb 10, 2026 · Common Stock · reported falling below 5%, from 5.85% in Nov 21, 2025
Raymond Debbane
SCHEDULE 13G/A · filed May 4, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.1% in Feb 13, 2026
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 8.98% in May 13, 2026
Woodline Partners LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.6% in May 15, 2026
Nextech Crossover I GP S.a. r.l.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 5.1% in May 15, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.01% in Jan 30, 2026
EcoR1 Capital, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock · reported falling below 5%, from 9.9% in Feb 14, 2025
What TNGX reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 18, 2024.
Insider tradesForm 4
29sales
0purchases
23sales on a scheduled plan
4people selling
$8.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 41 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Crystal Adam | President, R&D | 20 | $7.1M | 18 | 0 | $0 |
| Weber Barbara | Director, Executive Chair | 2 | $400,000 | 0 | 0 | $0 |
| Newcomb Jessica | Principal Accounting Officer | 5 | $400,000 | 5 | 0 | $0 |
| Beckman Daniella | Chief Financial Officer | 2 | $100,000 | 0 | 0 | $0 |